Trial intelligence / Profile preview

Selenium in radiochemotherapy-induced mucositis in head and neck cancer

IRCT2014072718612N1Phase 2Completed

Sponsor
Research Center of Rational Drug Use
Start
Nov 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of selenium in Malignant melanoma of the face (MM), Melanoma of the Lip (LM), nasal cavity cancer and 5 more, sponsored by Research Center of Rational Drug Use. Started Nov 2014; status: completed.

02

Drugs

selenium
03

Conditions

Malignant melanoma of the face (MM)Melanoma of the Lip (LM)nasal cavity cancermiddle ear carcinomaParanasal sinus carcinoma (PNSC)

Beyond the preview

Go deeper on IRCT2014072718612N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014072718612N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call